Femasys (FEMY) Preferred Stock Liabilities (2020 - 2021)
Femasys (FEMY) posted Preferred Stock Liabilities of $55.3 million for Q1 2021, little changed on a QoQ basis from $55.3 million in Q4 2020.
Femasys (FEMY) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends
Femasys' Preferred Stock Liabilities history runs 2 years deep, the most recent figure standing at $55.3 million for Q1 2021.
- Quarterly Preferred Stock Liabilities changed N/A year-over-year to $55.3 million in Q1 2021, while the trailing twelve-month figure through Mar 2021 was $55.3 million (changed N/A YoY) and the FY2020 annual result came in at $55.3 million, changed N/A from the prior year.
- Preferred Stock Liabilities was $55.3 million for Q1 2021 at Femasys, roughly flat from $55.3 million in the prior quarter.
- Across five years, Preferred Stock Liabilities topped out at $55.3 million in Q2 2020 and bottomed at $55.3 million in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | - |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | - |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | - |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | - |
| 10 | Femasys | 17.46 Mn | 12.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 55.34 Mn |
| Dec 31, 2020 | 55.34 Mn |
| Sep 30, 2020 | 55.34 Mn |
| Jun 30, 2020 | 55.34 Mn |